Abstract:Bipolar disorder (BD) showed the highest suicide rate of all psychiatric disorders, and its underlying causative genes and effective treatments remain unclear. During diagnosis, BD is often confused with schizophrenia (SC) and major depressive disorder (MDD), due to which patients may receive inadequate or inappropriate treatment, which is detrimental to their prognosis. This study aims to establish a diagnostic model to distinguish BD from SC and MDD in multiple public datasets through bioinformatics and machine learning and to provide new ideas for diagnosing BD in the future. Three brain tissue datasets containing BD, SC, and MDD were chosen from the Gene Expression Omnibus database (GEO), and two peripheral blood datasets were selected for validation. Linear Models for Microarray Data (Limma) analysis was carried out to identify differentially expressed genes (DEGs). Functional enrichment analysis and machine learning were utilized to identify. Least absolute shrinkage and selection operator (LASSO) regression was employed for identifying candidate immune-associated central genes, constructing protein-protein interaction networks (PPI), building artificial neural networks (ANN) for validation, and plotting receiver operating characteristic curve (ROC curve) for differentiating BD from SC and MDD and creating immune cell infiltration to study immune cell dysregulation in the three diseases. RBM10 was obtained as a candidate gene to distinguish BD from SC. Five candidate genes (LYPD1, HMBS, HEBP2, SETD3, and ECM2) were obtained to distinguish BD from MDD. The validation was performed by ANN, and ROC curves were plotted for diagnostic value assessment. The outcomes exhibited the prediction model to have a promising diagnostic value. In the immune infiltration analysis, Naive B, Resting NK, and Activated Mast Cells were found to be substantially different between BD and SC. Naive B and Memory B cells were prominently variant between BD and MDD. In this study, RBM10 was found as a candidate gene to distinguish BD from SC; LYPD1, HMBS, HEBP2, SETD3, and ECM2 serve as five candidate genes to distinguish BD from MDD. The results obtained from the ANN network showed that these candidate genes could perfectly distinguish BD from SC and MDD (76.923% and 81.538%, respectively).

Immune-based Machine learning prediction of diagnosis and illness state in schizophrenia and bipolar disorder

Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers

Identification of Immune-Related Biomarkers of Schizophrenia in the Central Nervous System Using Bioinformatic Methods and Machine Learning Algorithms

Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms

A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorder

Identification of the role of immune-related genes in the diagnosis of bipolar disorder with metabolic syndrome through machine learning and comprehensive bioinformatics analysis

Disease diagnostics using machine learning of immune receptors

Machine learning with multiple modalities of brain magnetic resonance imaging data to identify the presence of bipolar disorder

From periphery immunity to central domain through clinical interview as a new insight on schizophrenia

Using machine learning to understand social isolation and loneliness in schizophrenia, bipolar disorder, and the community

An integrated machine learning framework for a discriminative analysis of schizophrenia using multi-biological data

Role of different omics data in the diagnosis of schizophrenia disorder: A machine learning study

Machine‐based learning of multidimensional data in bipolar disorder – pilot results

Machine learning for precision diagnostics of autoimmunity

Machine learning methods to predict outcomes of pharmacological treatment in psychosis

A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup

A Novel Machine-learning Model to Classify Schizophrenia Using Methylation Data Based on Gene Expression

Integrating machining learning and multimodal neuroimaging to detect schizophrenia at the level of the individual

Machine learning applied to the prediction of relapse, hospitalization, and suicide in bipolar disorder using neuroimaging and clinical data: A systematic review

Unveiling the potential of machine learning in schizophrenia diagnosis: A meta-analytic study of task-based neuroimaging data

Predicting diagnostic progression to schizophrenia or bipolar disorder via machine learning applied to electronic health record data